NCT00354302 - Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial | Biotech Hunter

Enrollment

497

Participants

Timeline

Start Date

April 24, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

January 6, 2012

Conditions

Breast CancerOsteoporosis

Interventions

DIETARY_SUPPLEMENT

calcium carbonate

DIETARY_SUPPLEMENT

calcium citrate

DIETARY_SUPPLEMENT

cholecalciferol

DRUG

alendronate sodium

DRUG

calcium gluconate

DRUG

risedronate sodium

OTHER

laboratory biomarker analysis

PROCEDURE

dual x-ray absorptometry

Trial Locations (13)

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6Z8

The Moncton Hospital, Moncton

E2L 4L2

Atlantic Health Sciences Corporation, Saint John

N1R 3G2

Cambridge Memorial Hospital, Cambridge

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

P7B 6V4

Thunder Bay Regional Health Science Centre, Thunder Bay

M4N 3M5

Odette Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

J4V 2H1

Hopital Charles LeMoyne, Greenfield Park

G1S 4L8

CHA-Hopital Du St-Sacrement, Québec

S4T 7T1

Allan Blair Cancer Centre, Regina